Skip to main content

Table 2 Incremental costs and effectiveness for each strategy

From: Antibiotic prophylaxis at the time of dental implant placement: a cost-effectiveness analysis

Strategy

Cost (EUR)

Incremental Cost

Effectiveness (GOHAI)

Incremental E

ICER

NMB

 

Societal perspective

 All referencing common baseline

  Antibiotics

1037,61

 

0,879,495

  

1600,87

undominated

abs. Dominated

  No Antibiotics

1042, 56

4,95

0,878,208

−0,00129

−3841,18

1592,06

Patient’s perspective

 All referencing common baseline

  Antibiotics

1023,64

 

0,879,495

  

1614,84

undominated

abs. Dominated

  No Antibiotics

1042,56

18,92

0,878,208

−0,00129

−14,692,64

1592,06

  1. C Costs, E Effectiveness, abs Absolutely, NMB Net Monetary Benefit, ICER Incremental Cost-Effectiveness Ratio